Tempus AI, Inc.
TEMAPI behind this page
TEM Q1 2026 request
Playground key active
/api/financials?ticker=TEM&year=2026&quarter=1
Pick an endpoint and run the request.Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 348,116 | 255,737 | +36.1% |
Show Product Lines breakouts |
|||
| Clinical Order [Member] · Third Party Payor | 239.3 | 181.5 | +31.8% |
| Data and applications [Member] | 87,018 | 61,933 | +40.5% |
| Diagnostics [Member] | 261,098 | 193,804 | +34.7% |
| Genomics Product [Member] · Self Pay | 21.8 | 12.3 | +77.2% |
| Insights Product [Member] | 71.3 | 49.5 | +44.0% |
| Next Product [Member] | 5.7 | 2.7 | +111.1% |
| Trials Product [Member] | 9.9 | 9.7 | +2.1% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 21,823 | 631 | +3358.5% |
| SB Tempus Corp [Member] · Data License Agreement [Member] | 6.2 | 6.2 | 0.0% |
| Cost of Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Data and applications [Member] | 25,115 | 15,751 | +59.5% |
| Diagnostics [Member] | 100,960 | 84,783 | +19.1% |
| Technology Research And Development Expenses | 45,921 | 33,391 | +37.5% |
| Research & Development | 48,237 | 35,874 | +34.5% |
| Selling, General & Administrative | 212,594 | 154,627 | +37.5% |
| Total Costs & Expenses | 432,827 | 324,426 | +33.4% |
| Operating Income | -84,711 | -68,689 | -23.3% |
| Interest Income | 3,866 | 1,813 | +113.2% |
| Interest Expense Debt | -14,341 | -18,003 | +20.3% |
| Other Non-Operating Income (Expense) | -27,709 | -27,455 | -0.9% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -122,895 | -112,334 | -9.4% |
| Income Tax Expense (Benefit) | 62 | 46,180 | -99.9% |
Show Range breakouts |
|||
| Maximum | 0.1 | 46.2 | -99.8% |
| Income Loss From Equity Method Investments | -3,086 | -1,883 | -63.9% |
| Net Income | -125,919 | -68,037 | -85.1% |
Show Equity Components breakouts |
|||
| Retained Earnings | -125,919 | -68,037 | -85.1% |
| EPS (Basic) | -0.7 | -0.4 | -75.0% |
| EPS (Diluted) | -0.71 | -0.4 | -77.5% |
| Wtd Avg Shares (Basic) | 178,880 | 170,506 | +4.9% |
| Wtd Avg Shares (Diluted) | 178,964 | 170,506 | +5.0% |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -1,810 | 4,598 | -139.4% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -1,810 | 4,598 | -139.4% |
| Comprehensive Income | -127,729 | -63,439 | -101.3% |
| Revenue (Q) | — | — | — |
Show Period [Axis] breakouts |
|||
| Nine Months Ended Thirty First Of December Two Thousand And Twenty Six [Member] · Term Loans | 1.1 | — | — |
| Labor And Related Expense | 79,142 | 61,427 | +28.8% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 521,170 | 151,603 | +243.8% |
| Accounts Receivable | 308,599 | — | — |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 15,690 | — | — |
| Inventory | 51,831 | 50,485 | +2.7% |
| Other Receivables Net Current | 11,910 | — | — |
| Prepaid Expenses & Other Current Assets | 42,530 | 42,086 | +1.1% |
| Equity Securities Fv Ni | 117,902 | 67,183 | +75.5% |
| Total Current Assets | 1,053,942 | — | — |
Show Related Party Transactions By Related Party breakouts |
|||
| Pathos [Member] | 11.9 | — | — |
| Non-Current Assets | |||
| Property, Plant & Equipment | 88,593 | 93,536 | -5.3% |
| Goodwill | 470,169 | 325,774 | +44.3% |
| Related Party Asset Noncurrent | 13,090 | — | — |
| Operating Lease Right-of-Use Assets | 62,306 | 39,626 | +57.2% |
| Restricted Cash Noncurrent | 4,694 | 1,723 | +172.4% |
| Total Assets | 2,135,091 | 1,543,137 | +38.4% |
| Intangible Assets | 330,568 | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 196,853 | — | — |
| Developed Biotechnology [Member] | 87,400 | — | — |
| Developed Software Technology [Member] | 11,000 | — | — |
| Licensed data [Member] | 4,672 | — | — |
| Trade Names | 30,643 | — | — |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill Net Of Amortization And Impairment Charges | 330,587 | 399,544 | -17.3% |
| Capitalized Computer Software Net | 9,505 | — | — |
| Investments And Other Noncurrent Assets | 20,530 | 14,811 | +38.6% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 81,675 | 94,153 | -13.3% |
| Current Liabilities | |||
| Accounts Payable | 41,023 | 88,732 | -53.8% |
| Accrued Liabilities | 160,628 | 129,238 | +24.3% |
| Deferred Revenue (Current) | 72,866 | — | — |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | 403 | — | — |
| Contract With Customer Liability Other | 15,955 | 15,955 | 0.0% |
| Other Liabilities Current | 10,248 | 18,194 | -43.7% |
| Operating Lease Liability Current | 12,639 | 9,420 | +34.2% |
| Accrued Licensing Data Fees Current | 4,597 | 1,500 | +206.5% |
| Total Current Liabilities | 317,956 | 336,470 | -5.5% |
| Interest Payable Non Current | 15,844 | 1,470 | +977.8% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 72,723 | 47,567 | +52.9% |
| Convertible Debt Noncurrent | 199,279 | 233,620 | -14.7% |
| Other Non-Current Liabilities | 54,115 | 9,670 | +459.6% |
| Contract With Customer Liability Other Noncurrent | 3,989 | 19,944 | -80.0% |
| Contract With Customer Liability Noncurrent | 20,889 | — | — |
| Total Liabilities | 1,718,686 | 1,216,943 | +41.2% |
| Other Liabilities | |||
| Line Of Credit | 100,000 | 100,000 | 0.0% |
| Long Term Loans Payable | 204,624 | 467,144 | -56.2% |
| Convertible Senior Notes Net | 729,267 | — | — |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show Statement Class Of Stock breakouts |
|||
| Common Class A | 17 | 17 | 0.0% |
| Common Class B | 1 | 1 | 0.0% |
| Treasury Stock Common Value | -6,642 | -3,602 | -84.4% |
| Additional Paid In Capital Common Stock | 2,945,718 | 2,543,957 | +15.8% |
| Accumulated Other Comprehensive Income | -908 | 4,692 | -119.4% |
| Retained Earnings | -2,521,781 | -2,218,871 | -13.7% |
| Total Stockholders' Equity | 416,405 | 326,194 | +27.7% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 908 | 4,692 | -80.6% |
| Additional Paid In Capital | 2,945,718 | 2,543,957 | +15.8% |
| Common Stock · Common Class A | 17 | 17 | 0.0% |
| Common Stock · Common Class B | 1 | 1 | 0.0% |
| Retained Earnings | -2,521,781 | -2,218,871 | -13.7% |
| Treasury Stock Common | -6,642 | -3,602 | -84.4% |
| Total Liabilities & Equity | 2,135,091 | 1,543,137 | +38.4% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Stock-Based Compensation | 52,706 | 22,974 | +129.4% |
| Equity Securities Fv Ni Gain Loss | 32,309 | 31,805 | +1.6% |
| Gain Loss On Sale Of Property Plant Equipment | 334 | — | — |
| Amortization Of Debt Discount Premium | 1,448 | 560 | +158.6% |
Show Long-Term Debt Type breakouts |
|||
| Convertible Senior Notes [Member] | 1.2 | — | — |
| Amortization of Financing Costs | 86 | 157 | -45.2% |
| Business Combination Contingent Consideration Arrangements Change In Fair Value Of Holdback Liability | -1,167 | 46 | -2637.0% |
| Depreciation Of Tangible Assets And Amortization Of Intangible Assets | 26,175 | 20,353 | +28.6% |
| Provision For Doubtful Accounts | 636 | 316 | +101.3% |
| Provision For Obsolete Inventory | 225 | — | — |
| Operating Lease Right Of Use Asset Amortization Expense | 3,502 | 2,089 | +67.6% |
| Accretion Expense | 57 | 248 | -77.0% |
| Paid In Kind Interest | 1,674 | 3,274 | -48.9% |
| Change in Accounts Receivable | 1,990 | -45,175 | +104.4% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | -9,262 | 3,603 | -357.1% |
| Change in Inventory | -332 | -911 | +63.6% |
| Change in Prepaid & Other Assets | -2,032 | -5,798 | +65.0% |
| Increase Decrease In Investments And Other Current Assets | 433 | -3,358 | +112.9% |
| Change in Accounts Payable | -50,553 | 23,572 | -314.5% |
| Change in Deferred Revenue | -19,297 | -12,377 | -55.9% |
Show Related Party Transactions By Related Party breakouts |
|||
| Related Party | -3,535 | 300 | -1278.3% |
| Increase Decrease In Contract With Customer Liability Other | -3,989 | -3,988 | -0.0% |
| Increase Decrease In Accrued Data Licensing Fees | -6 | -250 | +97.6% |
| Increase Decrease In Other Accrued Liabilities | 5,257 | -27,606 | +119.0% |
| Increase Decrease In Interest Payable Net | 3,677 | 3,508 | +4.8% |
| Increase Decrease In Operating Lease Liability | -3,577 | -2,693 | -32.8% |
| Net Cash from Operations | -73,277 | -105,624 | +30.6% |
| Investing Activities | |||
| Capital Expenditures | -8,202 | -2,074 | -295.5% |
| Proceeds From Sale Of Equity Securities Fv Ni (Q) | — | — | — |
Show Financial Instrument breakouts |
|||
| Investment In Recursion Pharmaceuticals Class A Common Stock [Member] | 8.3 | — | — |
| Payments To Acquire Software | -1,865 | -1,298 | -43.7% |
| Net Cash from Investing | -10,067 | -375,818 | +97.3% |
| Redemption Of Convertible Promissory Note | 9,393 | 7,060 | +33.0% |
| Capitalized Software Costs Accrued But Not Yet Paid | 2,129 | — | — |
| Deferred Offering Costs Accrued But Not Yet Paid | 100 | — | — |
| Financing Activities | |||
| Debt Issuance Costs | -45 | — | — |
| Payment Of Deferred Financing Fees | -226 | -958 | +76.4% |
| Net Cash from Financing | -271 | 293,042 | -100.1% |
| Supplemental | |||
| Interest Paid | 9,322 | 10,849 | -14.1% |
Show Long-Term Debt Type breakouts |
|||
| Convertible Senior Notes [Member] | 3 | — | — |
| Term Loans | 6.3 | — | — |
| Income Taxes Paid | -56 | — | — |
| Unpaid Capital Expenditures | 4,592 | 7,003 | -34.4% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 28 | -109 | +125.7% |
| Net Change in Cash | -83,587 | -188,509 | +55.7% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 525,864 | 153,326 | +243.0% |
| Restricted Cash And Cash Equivalents | 4,694 | 1,723 | +172.4% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.